Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 9:11:618428.
doi: 10.3389/fimmu.2020.618428. eCollection 2020.

Discordance Between the Predicted Versus the Actually Recognized CD8+ T Cell Epitopes of HCMV pp65 Antigen and Aleatory Epitope Dominance

Affiliations

Discordance Between the Predicted Versus the Actually Recognized CD8+ T Cell Epitopes of HCMV pp65 Antigen and Aleatory Epitope Dominance

Alexander A Lehmann et al. Front Immunol. .

Abstract

CD8+ T cell immune monitoring aims at measuring the size and functions of antigen-specific CD8+ T cell populations, thereby providing insights into cell-mediated immunity operational in a test subject. The selection of peptides for ex vivo CD8+ T cell detection is critical because within a complex antigen exists a multitude of potential epitopes that can be presented by HLA class I molecules. Further complicating this task, there is HLA class I polygenism and polymorphism which predisposes CD8+ T cell responses towards individualized epitope recognition profiles. In this study, we compare the actual CD8+ T cell recognition of a well-characterized model antigen, human cytomegalovirus (HCMV) pp65 protein, with its anticipated epitope coverage. Due to the abundance of experimentally defined HLA-A*02:01-restricted pp65 epitopes, and because in silico epitope predictions are most advanced for HLA-A*02:01, we elected to focus on subjects expressing this allele. In each test subject, every possible CD8+ T cell epitope was systematically covered testing 553 individual peptides that walk the sequence of pp65 in steps of single amino acids. Highly individualized CD8+ T cell response profiles with aleatory epitope recognition patterns were observed. No correlation was found between epitopes' ranking on the prediction scale and their actual immune dominance. Collectively, these data suggest that accurate CD8+ T cell immune monitoring may necessitate reliance on agnostic mega peptide pools, or brute force mapping, rather than electing individual peptides as representative epitopes for tetramer and other multimer labeling of surface antigen receptors.

Keywords: ELISPOT; ImmunoSpot; brute force epitope mapping; epitope prediction; high throughput.

PubMed Disclaimer

Conflict of interest statement

AL, TZ, and PL are employees of Cellular Technology Limited (CTL), a company that specializes on immune monitoring via ELISPOT testing, producing high-throughput-suitable readers, test kits, and offering GLP-compliant contract research. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Predicted vs. actual pp65 epitope recognition by CD8+ T cells. Data are shown for subject ID 7 expressing the specified HLA alleles and responding to the listed peptides. Super-dominant responses are shown as red data points, dominant responses in black and weaker responses are not represented. The raw data for the peptide-induced SFU counts are listed in Table 1 . The corresponding Percentile Binding Score as established by the netMHCIpan search engine is shown comparing a peptide’s binding relative to the binding scores computed for 1,000 random nonamer peptides. A lower percentile binding score denotes better peptide binding to the specified HLA allele.

Similar articles

Cited by

References

    1. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol (1993) 11:729–66. 10.1146/annurev.iy.11.040193.003501 - DOI - PubMed
    1. Fernandes JD, Hinrichs AS, Clawson H, Gonzalez JN, Lee BT, Nassar LR, et al. The UCSC SARS-CoV-2 Genome Browser. Nat Genet (2020) 52:991–8. 10.1038/s41588-020-0700-8 - DOI - PMC - PubMed
    1. Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol (2011) 11:823–36. 10.1038/nri3084 - DOI - PubMed
    1. Antón LC, Yewdell JW. Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors. J Leukocyte Biol (2014) 95:551–62. 10.1189/jlb.1113599 - DOI - PMC - PubMed
    1. Williams TM. Human leukocyte antigen gene polymorphism and the histocompatibility laboratory. J Molec Diagnostics (2001) 3:98–104. 10.1016/S1525-1578(10)60658-7 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances